Furthermore, along with our recent study indicating an antitumour effect of anti-CD26 mAb (Ho et al, 2001), our findings may provide insights into the design of future novel treatments against selected human tumours based on our knowledge of CD26 biology. The gene discussed is DPP4; the disease is neoplasm.